Effects of carboxymethylcellulose and hydroxypropylmethylcellulose on the differentiation and activity of osteoclasts and osteoblasts

Journal of Biomedical Materials Research - Part A

Volumn 95 A, Issue 2, 2010, Pages 504-509

  Agis, Hermann ^a,b   Beirer, Benedict ^a,b   Watzek, Georg ^a,b   Gruber, Reinhard ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Austrian Cluster for Tissue Regeneration   (Austria)

Author keywords

bone graft; bone regeneration; cytotoxicity; osteoblast; osteoclast

Indexed keywords

BONE GRAFT; BONE MARROW; BONE REGENERATION; BONE SUBSTITUTES; CARBOXYMETHYLCELLULOSE; CELLULAR PROCESS; COLORIMETRIC MEASUREMENT; DEFECT SITES; FORMAZAN; GROWTH FACTOR; HIGH VISCOSITIES; HYDROXYPROPYL METHYLCELLULOSE; IN-VITRO; MARKER GENES; MULTINUCLEATED CELLS; OSTEOBLASTOGENESIS; OSTEOCLAST; OSTEOCLASTOGENESIS; REMARKABLE IMPACT;

ACIDS; GENE EXPRESSION; GRAFTING (CHEMICAL); OSTEOBLASTS; PHOSPHATASES;

BONE;

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE; CARBOXYMETHYLCELLULOSE; COLLAGEN TYPE 1; FORMAZAN; HYDROXYPROPYLMETHYLCELLULOSE; OSTEOCALCIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL ACTIVITY; CELL DIFFERENTIATION; CELL VIABILITY; COLORIMETRY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; MARKER GENE; MULTINUCLEAR CELL; NONHUMAN; OSTEOBLAST; OSTEOBLASTOGENESIS; OSTEOCLAST; OSTEOCLASTOGENESIS; VISCOSITY;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOLOGICAL MARKERS; BONE MARROW CELLS; BONE REGENERATION; CARBOXYMETHYLCELLULOSE SODIUM; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; DRUG CARRIERS; FEMALE; MATERIALS TESTING; METHYLCELLULOSE; MICE; OPHTHALMIC SOLUTIONS; OSTEOBLASTS; OSTEOCLASTS; STEM CELLS;

EID: 78649304747     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32842     Document Type: Article

References (30)

1. Duggirala SS, Rodgers JB, DeLuca PP,. The evaluation of lyophilized polymer matrices for administering recombinant human bone morphogenetic protein-2. Pharm Dev Technol 1996; 1: 165-174.
2. Rodgers JB, Vasconez HC, Wells MD, DeLuca PP, Faugere MC, Fink BF, Hamilton D,. Two lyophilized polymer matrix recombinant human bone morphogenetic protein-2 carriers in rabbit calvarial defects. J Craniofac Surg 1998; 9: 147-153.
3. Santa-Comba A, Pereira A, Lemos R, Santos D, Amarante J, Pinto M, Tavares P, Bahia F,. Evaluation of carboxymethylcellulose, hydroxypropylmethylcellulose, and aluminum hydroxide as potential carriers for rhBMP-2. J Biomed Mater Res A 2001; 55: 396-400.
4. Woo BH, Fink BF, Page R, Schrier JA, Jo YW, Jiang G, DeLuca M, Vasconez HC, DeLuca PP,. Enhancement of bone growth by sustained delivery of recombinant human bone morphogenetic protein-2 in a polymeric matrix. Pharm Res 2001; 18: 1747-1753.
5. Cook SD, Salkeld SL, Patron LP,. Bone defect healing with an osteogenic protein-1 device combined with carboxymethylcellulose. J Biomed Mater Res B Appl Biomater 2005; 75: 137-145.
6. Matos SM, Guerra FA, Krauser J, Marques F, Ermida JM, Sanz M,. Clinical evaluation of the combination of anorganic bovine-derived hydroxyapatite matrix/cell-binding peptide (P-15) in particulate and hydrogel form as a bone replacement graft material in human periodontal osseous defects: 6-month reentry controlled clinical study. J Periodontol 2007; 78: 1855-1863.
7. Trojani C, Boukhechba F, Scimeca JC, Vandenbos F, Michiels JF, Daculsi G, Boileau P, Weiss P, Carle GF, Rochet N,. Ectopic bone formation using an injectable biphasic calcium phosphate/Si-HPMC hydrogel composite loaded with undifferentiated bone marrow stromal cells. Biomaterials 2006; 27: 3256-3264.
8. Fellah BH, Weiss P, Gauthier O, Rouillon T, Pilet P, Daculsi G, Layrolle P,. Bone repair using a new injectable self-crosslinkable bone substitute. J Orthop Res 2006; 24: 628-635.
9. Xu HH, Takagi S, Quinn JB, Chow LC,. Fast-setting calcium phosphate scaffolds with tailored macropore formation rates for bone regeneration. J Biomed Mater Res A 2004; 68: 725-734.
10. Morio D, Lew D, Krizan K, Keller JC,. Short-term bone responses to hydroxyapatite cement. Implant Dent 2002; 11: 376-382.
11. Clarke SA, Hoskins NL, Jordan GR, Henderson SA, Marsh DR,. In vitro testing of Advanced JAX Bone Void Filler System: Species differences in the response of bone marrow stromal cells to beta tri-calcium phosphate and carboxymethylcellulose gel. J Mater Sci Mater Med 2007; 18: 2283-2290.
12. Nguyen H, Qian JJ, Bhatnagar RS, Li S,. Enhanced cell attachment and osteoblastic activity by P-15 peptide-coated matrix in hydrogels. Biochem Biophys Res Commun 2003; 311: 179-186.
13. Trojani C, Weiss P, Michiels JF, Vinatier C, Guicheux J, Daculsi G, Gaudray P, Carle GF, Rochet N,. Three-dimensional culture and differentiation of human osteogenic cells in an injectable hydroxypropylmethylcellulose hydrogel. Biomaterials 2005; 26: 5509-5517.
14. Gerstenfeld LC, Sacks DJ, Pelis M, Mason ZD, Graves DT, Barrero M, Ominsky MS, Kostenuik PJ, Morgan EF, Einhorn TA,. Comparison of effects of the bisphosphonate alendronate versus the RANKL inhibitor denosumab on murine fracture healing. J Bone Miner Res 2009; 24: 196-208.
15. Schindeler A, McDonald MM, Bokko P, Little DG,. Bone remodeling during fracture repair: The cellular picture. Semin Cell Dev Biol 2008; 19: 459-466.
16. Berglundh T, Abrahamsson I, Lang NP, Lindhe J,. De novo alveolar bone formation adjacent to endosseous implants. Clin Oral Implants Res 2003; 14: 251-262.
17. Patntirapong S, Habibovic P, Hauschka PV,. Effects of soluble cobalt and cobalt incorporated into calcium phosphate layers on osteoclast differentiation and activation. Biomaterials 2009; 30: 548-555.
18. Handschel J, Berr K, Depprich RA, Kubler NR, Naujoks C, Wiesmann HP, Ommerborn MA, Meyer U,. Induction of osteogenic markers in differentially treated cultures of embryonic stem cells. Head Face Med 2008; 4: 10.
19. Jansen ID, Mardones P, Lecanda F, de Vries TJ, Recalde S, Hoeben KA, Schoenmaker T, Ravesloot JH, van Borren MM, van Eijden TM, others. Ae2(a,b)-deficient mice exhibit osteopetrosis of long bones but not of calvaria. Faseb J 2009; 23: 3470-3481.
20. Kovacic N, Lukic IK, Grcevic D, Katavic V, Croucher P, Marusic A,. The Fas/Fas ligand system inhibits differentiation of murine osteoblasts but has a limited role in osteoblast and osteoclast apoptosis. J Immunol 2007; 178: 3379-3389.
21. Mullender MG, Krijnen MR, Helder MN, Smit TH, Everts V, Wuisman PI,. Lumbar body fusion with a bioresorbable cage in a goat model is delayed by the use of a carboxymethylcellulose-stabilized collagenous rhOP-1 device. J Orthop Res 2007; 25: 132-141.
22. Phillips FM, Turner AS, Seim HB, III, MacLeay J, Toth CA, Pierce AR, Wheeler DL,. In vivo BMP-7 (OP-1) enhancement of osteoporotic vertebral bodies in an ovine model. Spine J 2006; 6: 500-506.
23. Pluhar GE, Turner AS, Pierce AR, Toth CA, Wheeler DL,. A comparison of two biomaterial carriers for osteogenic protein-1 (BMP-7) in an ovine critical defect model. J Bone Joint Surg Br 2006; 88: 960-966.
24. Ripamonti U,. Bone induction by recombinant human osteogenic protein-1 (hOP-1. BMP-7) in the primate Papio ursinus with expression of mRNA of gene products of the TGF-beta superfamily. J Cell Mol Med 2005; 9: 911-928.
25. Springer IN, Acil Y, Kuchenbecker S, Bolte H, Warnke PH, Abboud M, Wiltfang J, Terheyden H,. Bone graft versus BMP-7 in a critical size defect-cranioplasty in a growing infant model. Bone 2005; 37: 563-569.
26. Vaccaro AR, Patel T, Fischgrund J, Anderson DG, Truumees E, Herkowitz HN, Phillips F, Hilibrand A, Albert TJ, Wetzel T, McCulloch J,. A pilot study evaluating the safety and efficacy of OP-1 Putty (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis for degenerative spondylolisthesis. Spine 2004; 29: 1885-1892.
27. Wang H, Springer IN, Schildberg H, Acil Y, Ludwig K, Rueger DR, Terheyden H,. Carboxymethylcellulose-stabilized collagenous rhOP-1 device-a novel carrier biomaterial for the repair of mandibular continuity defects. J Biomed Mater Res A 2004; 68: 219-226.
28. Reynolds MA, Aichelmann-Reidy ME, Kassolis JD, Prasad HS, Rohrer MD,. Calcium sulfate-carboxymethylcellulose bone graft binder: Histologic and morphometric evaluation in a critical size defect. J Biomed Mater Res B Appl Biomater 2007; 83: 451-458.
29. Gauthier O, Bouler JM, Weiss P, Bosco J, Aguado E, Daculsi G,. Short-term effects of mineral particle sizes on cellular degradation activity after implantation of injectable calcium phosphate biomaterials and the consequences for bone substitution. Bone 1999; 25 (2 Suppl): 71S-74S.
30. Woo KM, Yu B, Jung HM, Lee YK,. Comparative evaluation of different crystal-structured calcium sulfates as bone-filling materials. J Biomed Mater Res B Appl Biomater 2009; 91: 545-554.